Newborn Screening in Japan
"Newborn Screening in Japan-2021" is a topical collection of the International Journal of Neonatal Screening. Japan's newborn mass screening (NBS) was started in 1977 at the national level as a national project. Subsequently, screening was conducted for six diseases. From 2014 a tande...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Book Chapter |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Subjects: | |
| Online Access: | Get Fullteks DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 04389naaaa2201105uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_78775 | ||
| 005 | 20220224 | ||
| 020 | |a books978-3-0365-2925-7 | ||
| 020 | |a 9783036529257 | ||
| 020 | |a 9783036529240 | ||
| 024 | 7 | |a 10.3390/books978-3-0365-2925-7 |c doi | |
| 041 | 0 | |a English | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 100 | 1 | |a Tajima, Toshihiro |4 edt | |
| 700 | 1 | |a Yamaguchi, Seiji |4 edt | |
| 700 | 1 | |a Tajima, Toshihiro |4 oth | |
| 700 | 1 | |a Yamaguchi, Seiji |4 oth | |
| 245 | 1 | 0 | |a Newborn Screening in Japan |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (116 p.) | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a "Newborn Screening in Japan-2021" is a topical collection of the International Journal of Neonatal Screening. Japan's newborn mass screening (NBS) was started in 1977 at the national level as a national project. Subsequently, screening was conducted for six diseases. From 2014 a tandem mass analyzer (tandem mass) was introduced nationwide, and in addition to the conventional amino acid metabolism disorders urea cycle disorders, organic acid metabolism disorders and fatty acid metabolism disorders have joined the target diseases. Screening is currently conducted for 20 diseases. The acceptance rate of mass screening in Japan is 100%, and top-level screening measures available in the world, such as a quality control system and an inspection system, are carried out. This book is an overview of the history, current status and future of NBS in Japan. I hope that readers are interested in this book. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a homocystinuria | ||
| 653 | |a cystathionine β-synthase deficiency | ||
| 653 | |a newborn screening | ||
| 653 | |a long-term outcome | ||
| 653 | |a social outcome | ||
| 653 | |a vitamin B6 | ||
| 653 | |a methionine | ||
| 653 | |a phenylketonuria | ||
| 653 | |a hyperphenylalaninemia | ||
| 653 | |a phenylalanine hydroxylase | ||
| 653 | |a genetic analysis | ||
| 653 | |a neonatal screening | ||
| 653 | |a genotype-phenotype correlation | ||
| 653 | |a adult patients | ||
| 653 | |a Japanese | ||
| 653 | |a intellectual disability | ||
| 653 | |a psychiatric disability | ||
| 653 | |a treatment discontinuation | ||
| 653 | |a congenital hypothyroidism | ||
| 653 | |a Japan | ||
| 653 | |a re-evaluations | ||
| 653 | |a prevalence | ||
| 653 | |a lowering of thyroid stimulating hormone screening cutoffs | ||
| 653 | |a thyroid dysgenesis | ||
| 653 | |a thyroid dyshormonogenesis | ||
| 653 | |a transient congenital hypothyroidism | ||
| 653 | |a permanent congenital hypothyroidism | ||
| 653 | |a delayed rise in TSH | ||
| 653 | |a low birth weight | ||
| 653 | |a propionic acidemia | ||
| 653 | |a tandem mass spectrometry | ||
| 653 | |a propionylcarnitine | ||
| 653 | |a cardiomyopathy | ||
| 653 | |a QT prolongation | ||
| 653 | |a congenital adrenal hyperplasia | ||
| 653 | |a 21-hydroxylase deficiency | ||
| 653 | |a methylmalonic acidemia | ||
| 653 | |a disorders of cobalamin metabolism | ||
| 653 | |a hypomethioninemia | ||
| 653 | |a isomer | ||
| 653 | |a stable-isotope dilution | ||
| 653 | |a derivatization | ||
| 653 | |a cobalamin | ||
| 653 | |a biotin | ||
| 653 | |a maternal 3-methylcronylglycinuria | ||
| 653 | |a argininosuccinic acid | ||
| 653 | |a spinal muscular atrophy | ||
| 653 | |a SMN1 | ||
| 653 | |a deletion | ||
| 653 | |a incidence | ||
| 653 | |a peroxisomal disorders | ||
| 653 | |a adrenoleukodystrophy | ||
| 653 | |a very-long-chain fatty acids | ||
| 653 | |a plasmalogen | ||
| 653 | |a phytanic acid | ||
| 653 | |a presymptomatic diagnosis | ||
| 653 | |a ABCD1 | ||
| 653 | |a whole-exome sequencing | ||
| 653 | |a dried blood spot | ||
| 653 | |a galactosemia | ||
| 653 | |a GALM | ||
| 653 | |a GALM deficiency | ||
| 653 | |a glycogen storage disease type 1a | ||
| 653 | |a allele-specific PCR | ||
| 653 | |a mCOP-PCR | ||
| 653 | |a melting curve | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4869 |7 0 |z Get Fullteks |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/78775 |7 0 |z DOAB: description of the publication |